Email updates

Keep up to date with the latest news and content from BMC Infectious Diseases and BioMed Central.

Open Access Highly Accessed Research article

Enterococcus and Streptococcus spp. associated with chronic and self-medicated urinary tract infections in Vietnam

Louise Ladefoged Poulsen1, Magne Bisgaard1, Nguyen Thai Son2, Nguyen Vu Trung3, Hoang Manh An2 and Anders Dalsgaard1*

Author affiliations

1 Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Groennegaardsvej 15 DK-1870, Frederiksberg C, Denmark

2 Hospital 103, Military Medical University, Ha Dong, Hanoi, Vietnam

3 Department of Medical Microbiology, Hanoi Medical University, Hanoi, Vietnam

For all author emails, please log on.

Citation and License

BMC Infectious Diseases 2012, 12:320  doi:10.1186/1471-2334-12-320


The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2334/12/320


Received:13 March 2012
Accepted:27 September 2012
Published:23 November 2012

© 2012 Poulsen et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Urinary tract infections (UTI) are one of the most common infections among women worldwide. E. coli often causes more than 75% of acute uncomplicated UTI, however, little is known about how recurrent UTIs and indiscriminate use of antimicrobials affect the aetiology of UTIs. This study aimed to establish the aetiology of UTI in a population of recurrent and self-medicated patients referred from pharmacies to a hospital in Hanoi, Vietnam and to describe genotypes and antimicrobial susceptibility of the associated bacterial pathogens. The aetiology of bacterial pathogens associated with UTI (defined as ≥ 104 CFU/ml urine) was established by phenotypic and molecular methods. Enterococcus faecalis isolates were typed by Multi Locus Sequence Typing (MLST), Pulsed-Field Gel Electrophoresis (PFGE) and antimicrobial susceptibility testing.

Methods

Urine samples from 276 patients suffering symptoms of urinary tract infection were collected and cultured on Flexicult agar® allowing for detection of the most common urine pathogens. Patients were interviewed about underlying diseases, duration of symptoms, earlier episodes of UTI, number of episodes diagnosed by doctors and treatment in relation to UTI. All tentative E. faecalis and E. faecium isolates were identified to species level by PCR, 16S rRNA and partial sequencing of the groEL gene. E. faecalis isolates were further characterized by Multi Locus Sequence Typing and antimicrobial susceptibility testing.

Results

Mean age of 49 patients was 48 yrs (range was 11–86 yrs) and included 94% women. On average, patients reported to have suffered from UTI for 348 days (range 3 days-10 years, and experienced 2.7 UTIs during the previous year). Cephalosporins were reported the second drug of choice in treatment of UTI at the hospital. E. faecalis (55.1%), E. coli (12.2%) and Streptococcus gallolyticus subsp. pasteurianus (8.2%) were main bacterial pathogens. MIC testing of E. faecalis showed susceptibility to ampicillin, penicillin and vancomycin, but high-level resistance against gentamicin (48.1%). MLST revealed 12 Sequence Types (ST) of which ST 16 made up 44.5% and showed closely related PFGE types.

Conclusion

The different aetiology of UTI compared with reports elsewhere, where E. coli dominates, may be a result of chronic and recurrent UTIs together with indiscriminate use of antimicrobials. The similar genotypes shown by epidemiologically unrelated ST 16 isolates in Vietnam and elsewhere, suggest that E. faecalis ST 16 might represent a globally distributed clone. Treatment of UTI with cephalosporins may select for E. faecalis as it is intrinsic resistant and further studies are needed to establish the source(s) and role of E. faecalis ST 16 in acute UTI.

Background

Urinary tract infection (UTI) represents one of the most common bacterial infections and it is estimated that 50% of all women will experience at least one episode of UTI during their life time [1,2]. The most frequently isolated pathogen is E. coli making up 50% to 70% of UTI cases [3]. Common laboratory diagnostic test for UTI include; leucocyte esterase test, nitrite test and culture for bacterial pathogens [4,5]. Although enterococci seem associated with a relative low percentage of community-acquired UTI’s [6], the prevalence of enterococci have increased in hospital-acquired infections in general, and now represent a common cause of hospital-acquired infections after E. coli and S. aureus[7]. Enterococci are intrinsic resistant to a number of antimicrobials [8] and can further easily acquire resistances which increase their potential to cause disease and spread in hospital environments [8]. The acquisition of high-level gentamicin resistance by enterococci in particular represents a health problem, since gentamicin is used in combination with cell-wall active compounds, i.e. ampicillin, penicillin or vancomycin, for treatment of endocarditis associated with enterococci [9].

Little is known about the incidence and aetiology of UTI in Vietnam and other less developed countries. This is partly because UTIs are most often not reportable diseases and self medication is common, so many infections are treated by patients or pharmacists alone [10]. It has previously been described that Vietnamese women use various forms of self-treatment to prevent and cure reproductive tract infections which may be potentially harmful and may favor opportunistic infections [11].

The objective of this study was to investigate the aetiology and patient characteristics of UTI among patients seen at a hospital in Hanoi, Vietnam, and establish the genotypes and antimicrobial resistance of E. faecalis, which appeared as the most common associated pathogen.

Methods

Recruitment of patients and urine collection

All urine samples were collected from January 2008 to January 2010 at the Military Medical University, Hospital 103 in Ha Dong, Hanoi. Nearby pharmacies were instructed to refer patients to Hospital 103 that reported at least one of the following clinical symptoms of UTI: frequent urination, painful urination, hematuria, cloudy urine, pain in pelvic area or lower back. A midstream urine sample was collected at the hospital under supervision of a nurse and bacteriological culture initiated immediately after collection. Based on the established aetiology and results of antimicrobial susceptibility testing, patients were informed about which antimicrobial agent should be used for treatment. All patients were informed orally and in writing in their own mother tongue about the possibility to participate in the study and withdraw at any time without explanation. After the information was given, patients signed an approved consent form. The study protocols were approved by the ethical committee at the Hospital 103. No patients refused to participate.

Bacterial culture of urine

Flexicult agar plates (Statens Serum Institute, Copenhagen, Denmark) were used for culturing urine [12]. According to the manufacturer pure cultures with ≥ 103 CFU per ml urine should be regarded positive, however, as a conservative measure and due to the findings of unusual aetiology we used a definition of ≥ 104 CFU per ml urine as a positive urine sample. The selective and indicative Flexicult agar plate allows for the detection of the 10 most common pathogens associated with UTI, including E. coli, Klebsiella spp., Enterobacter spp., and Proteus spp.[12]. Urine samples from a total of 276 patients were poured over Flexicult plates immediately after collection and incubated at 37°C for 18–24 hrs and if plates showed no visible growth for another 18–24 hrs. If plates showed growth of E. coli, E. faecium or E. faecalis in pure culture with ≥ 104 CFU per ml urine, three individual colonies were randomly picked from the control compartment in the plate and sub-cultured on non-selective LB agar, Lennox plates (DifcoTM, Becton, Dickinson and Company, Sparks, USA) which were incubated overnight at 37°C to obtain pure cultures. Colonies were subsequently grown overnight at 37°C in Brain Heart Infusion broth (Oxoid, Basingstoke, Hampshire, England) and stored for further characterization at – 80°C in Cryo tubes containing 30% glycerol. The identity of the three colonies was determined to confirm pure culture in the urine samples.

Patient questionnaire

All patients were interviewed when urine samples were taken. Registered personal data included: age and sex as well as self-reported underlying diseases, including hematological disorders, respiratory infections, diarrhoea, diabetes, cancer, HIV/AIDS, liver cirrhosis, alcoholism, anatomical malformations of urinary tract, and history of nephro- or urolithiasis. Patients reporting underlying diseases as described above as well as hospital-acquired infections were excluded. Thus, study subjects included those with acute, recurrent and/or self-medicated UTI. The following clinical symptoms were recorded: frequent urination, painful urination, cloudy urine, blood in urine, pain in pelvic area, pain in lower back and fever. In addition, information was recorded about duration of symptoms, previous episodes of UTI, number of UTI episodes during the last year and how many of these episodes were diagnosed by a doctor. Finally, medical treatment of UTI before enrolment in the study was registered, e.g. type of antimicrobial used.

PCR and 16S rRNA identification of enterococci

E. faecalis and E. faecium were identified by species-specific PCR [13]. Isolates tentatively identified as E. faecalis or E. faecium based on appearance on the Flexicult agar plate, but testing negative in the E. faecalis- /E. faecium-specific PCR (n=9), were characterized by 16S rRNA sequence analysis (Macrogen®, Seoul, South Korea) [14] using primers modified after [15]. Species identification was done by BLAST search in GenBank by use of the EzTaxon server ( http://www.eztaxon.org/ webcite).

Partial sequencing of groEL

The identity of Strepcococcus gallolyticus subsp. pasteurianus as shown by 16S rRNA sequence analysis was confirmed by partial sequencing (Macrogen®) of the groEL gene [16] which encodes a heat-shock protein. Sequences were assembled using CLC Main Workbench 5.2 software (CLC bio, Aarhus, Denmark) and species identification was done by blasting the sequences in the NCBI database ( http://www.ncbi.nlm.nih.gov/ webcite). To determine a more precise similarity between the obtained sequences and the sequence of the type strain, local pair wise sequence alignment was done, using EMBOSS water alignment ( http://www.ebi.ac.uk/ webcite).

Antimicrobial susceptibility testing

MIC were determined for 27 E. faecalis to ampicillin (AMP, 2–32 μg/ml), penicillin (PEN, 2–32 μg/ml), vancomycin (VAN, 1–32 μg/ml) and high-level gentamicin (GEN, 16–1024 μg/ml) using the Sensititre® system (Trek Diagnostics Systems, East Grindstead, England). The following breakpoint values as proposed by EUCAST (European Committee on Antimicrobial Susceptibility Testing; http://www.eucast.org/ webcite) were used: AMP R > 8 μg/ml, VAN R > 4 μg/ml where as R > 128 μg/ml was used for high-level GEN resistance.

Identification of aac (6’)-Ie aph (2”)-Ia resistance gene

All strains which had a MIC ≥ 512 μg/ml and three control strains which had a MIC ≤ 16 μg/ml against gentamicin were tested by PCR for the presence of the aac (6’)-Ie aph (2”)-Ia gene [17] which encodes high-level aminoglycoside resistance associated with transposons in E. faecalis (Tn5281), Staphylococcus aureus (Tn4001) and Staphylococcus epidermidis (Tn4031) [18].

MLST of E. faecalis

All urine isolates identified as E. faecalis (n=27) were characterized by MLST to investigate if certain STs were associated with UTI. One of the three E. faecalis isolates collected from each patient was randomly selected and characterized by full MLST sequence analyses of all seven genes (gdh, gyd, pstS, gki, aroE, xpt, and yqil). To confirm pure culture in the urine samples, a second isolate from each of 16 (28.1%) samples was typed by sequence analyses of the gki and yqil genes. Since the DNA sequence of the gki and yqil genes were identical for the two isolates characterized from individual urine samples further sequencing were not done on isolates from the remaining urine samples. The PCR primers and conditions used were those described on the E. faecalis-MLST website ( http://efaecalis.mlst.net/ webcite). Amplicons were sequenced in both directions (Macrogen®). DNA sequences were assembled and a sequence type was assigned to each strain using CLC Main Workbench 5.2 software (CLC bio, Aarhus, Denmark) and compared to published alleles ( http://efaecalis.mlst.net/ webcite).

PFGE

All urine isolates of ST 16 (n=12) were characterized by Pulsed-Field Gel Electrophoresis (PFGE) to determine their clonality and degree of similarity to four E. faecalis ST 16 strains isolated from Danish endocarditis patients [19]. DNA was prepared directly in a solid agarose plug (SeaKem Gold Agarose; Lonza, Basel, Switzerland) for restriction endonuclease digestion with the enzyme SmaI (BioLabs, New England, USA). The separations of fragments were done on CHEF-DR III (Bio-Rad, Richmond, CA, USA) at the following conditions: 6V/cm at 14°C for 20 h at a filed angel of 120°. The electrophoresis was carried out at switch times of 2.2 to 54.4 s. Following electrophoresis the gels were stained for 15 min in ethidium bromide (2 mg/ml water; Sigma-Aldrich Denmark A/S, Brøndby, DK), then destained in water for 15 min and visualized under UV light (Gel Doc, Bio-Rad) [20].

Results

Aetiology of UTI

Patients seen at the Hospital 103 with urine samples demonstrating pure cultures of ≥ 104 CFU per ml were considered cases of UTI yielding a total of 49/276 (17.8%) positive urine samples. Among the 227 urine samples regarded as negative, coagulase-negative staphylococci appearing with small white colonies on the Flexicult agar plate were observed in 128 samples (56.4%), while 89 (39.2%) samples demonstrated < 104 CFU per ml and/or mixed cultures, and 10 (4.4%) samples were sterile. Genus identification of bacterial colonies was based on their appearance on the chromogenic Flexicult agar according to the manufacturer’s instructions. Subsequently, species-specific PCR was used to identify E. faecalis and E. faecium and 16S rRNA sequence analysis was used to identify Streptococcus spp. and Enterococcus spp. which did not yield an amplicon in the E. faecalis- and E. faecium specific PCR. For Streptococcus spp. the results were confirmed by partial sequencing of GroEL. The bacterial aetiology could be established in 49 UTI cases (Table  1). 16S rRNA-based identification of four S. gallolyticus subsp. pasteurianus isolates was verified by sequencing of the GroEL gene and alignment with the sequence of the type strain [16] showing 100% similarity to the type strain. Thus, the sequencing of the GroEL gene thereby confirmed the 16S rRNA-based identification.

Table 1. Bacterial pathogens isolated from 49 patients with urinary tract infections (UTI) seen at a hospital in northern Vietnam

Characteristics of UTI patients

All 49 patients that showed ≥ 104 CFU in pure culture per ml urine lived in the Ha Dong area in Hanoi. The mean age was 48 yrs (range was 11–86 yrs) and included 46 women and 3 men. On average, patients reported to have suffered from UTI symptoms for 348 days (range 3 days-10 yrs) at the time of their enrolment in the study. About one third (30.6%) of the patients had suffered from UTI previously. On average, patients who previously suffered from UTI had experienced 2.7 episodes during the last year (range 1–15 with the majority of patients experiencing between 1 to 5 episodes) of which 60.0% of the cases were diagnosed by a doctor. Treatment with antimicrobials before visiting the hospital was reported by 36.7% of UTI patients. However, only seven patients remembered which antimicrobial they took (chloramphenicol (2), ofloxacin (1), ampicillin (2), amoxicillin (1) and cephalexin (1)). Nine (18.4%) patients had used Chinese or Vietnamese herb medicine instead of, or in combination with antimicrobials. Specific symptoms were not observed for the different bacterial species associated with UTI.

MLST and PFGE typing

All isolates identified as E. faecalis (n=27) by the species-specific PCR were characterized by MLST. A total of 12 sequence types (ST) was identified with ST 16 making up 44.4% of the isolates (Table  2).

Table 2. Distribution of MLST sequence types, and allelic profiles among E. faecalis isolated from UTI patients in Vietnam

The relatedness of PFGE types shown by the ST 16 isolates is shown in Figure  1. PFGE patterns of ten E. faecalis ST 16 isolated from UTI in Vietnam and four E. faecalis ST 16 isolated from patients with endocarditis in Denmark are shown as they represent the diversity seen for ST 16. All isolates shared 15 DNA fragments in their PFGE types. Five of the Vietnamese isolates and three of the Danish isolates (lanes 7 to 14) have an additional fragment of 750-kb size (Group B). Five Vietnamese isolates and one Danish isolate showed PFGE types without the 750-kb size fragment and are referred to as group A (lanes 2 to 6 and lane 15). When guidelines of Tenover et al.[21] are applied, all strains can be defined as closely related based on a maximum of three fragment difference.

thumbnailFigure 1. Pulsed-field gel electrophoresis (PFGE) of sma I digested E. faecalis ST 16 strains. Lanes 1 and 16 are molecular size markers. Lanes 2 to 11 show E. faecalis isolated from urinary tract infections in Vietnam and lanes 12 to 15 show E. faecalis isolated from Danish endocarditis patients. PFGE patterns of strains in lanes 2 to 6 and lane 15 are referred to as type A and lanes 7 to14 as type B.

Antimicrobial susceptibility testing and aac (6’)-Ie aph (2”)-Ia gene

All E. faecalis isolates were susceptible to ampicillin, penicillin and vancomycin. Resistance against high-level gentamicin was common (48.1%). All of the high-level gentamicin-resistant isolates contained the aac (6’)-Ie aph (2”)-Ia gene (n=24) whereas the three isolates with a MIC <=16 μg per ml did not harbour the gene.

Discussion

Our findings that E. faecalis was the most common pathogen associated with UTI are different to most previous studies where E. coli represents the main pathogen as e.g. in the international ECO.SENS study [3]. However, it should be mentioned that the ECO.SENS study as most other larger studies on UTI addressed only uncomplicated UTI cases. The patient characteristics found are in accordance with other studies with respect to age (mean age 48 yrs) and gender (94% women) [3]. However, the duration of symptoms and antimicrobial use patterns indicate recurrent, chronic and self-medicated UTIs. In our study, 30.6% of patients reported episodes of UTIs during the 12-month period before they enrolled in the study. Thus, the patients are likely to have suffered from recurrent UTIs and undertaken repeated self-medication, a practice which is described as widespread in Vietnam [10]. This situation may not be unique and can be expected in other countries with similar indiscriminate use of antimicrobials [22]. In addition, it appears as documented elsewhere [11] that the habit of some women to prevent and treat reproductive tract infections by vaginal douching with home prepared acidic solutions or commercial products as well as regular use of intra-vaginal antimicrobials may change the microflora in the genital tract and thus favor opportunistic infections. It is unknown to what extent such practices are associated with the atypical aetiology of UTI seen in our study. As antimicrobials are readily available at low costs for most Vietnamese, women suffering from acute UTI are likely to obtain antimicrobials for self-treatment at local pharmacies rather than signing up to take part in our study which will take their time and involve other people in their personal health problems. This may explain why mainly women suffering recurrent and complicated UTI (e.g. unknown underlying diseases) and showing atypical aetiology participated in our study.

About one third (37.6%) of the patients reported to have obtained antimicrobials from local pharmacies during a 12-month period before they were enrolled in the study; however, only seven patients were able to remember which type of antimicrobials they used. Further, patients were only asked if antimicrobials were used to treat UTI and they may have received additional antimicrobial treatments of other diseases. The first drug of choice used at the hospital to treat UTI was amoxicillin while the second drug of choice was cephalosporins which will select for E. faecalis due to its intrinsic resistance to cephalosporins [8]. Comparison of the prevalence of high-level gentamicin resistance reported from different geographic regions indicate that our finding of 48.1% resistant E. faecalis was higher than findings of 36% in a hospital in Denmark and 22% high-level gentamicin resistance in Greece [23,24], however, it should be noted that only a limited number of strains were included in our study. The gene aac (6’)-Ie aph (2”)-Ia was found in all strains showing high-level gentamicin resistance.

ST 16 made up 44.4% of the E. faecalis isolates recovered from UTI. In the MLST data-base ( http://efaecalis.mlst.net/ webcite), ST 16 is reported as the most frequent ST of E. faecalis recovered from clinical infections, faecal samples from hospitalized patients, healthy volunteers, and animals in Spain and the Netherlands [25]. The genotypes produced by PFGE confirms previous observations that E. faecalis ST 16 show little variation in PFGE patterns (1–3 fragment difference) which suggests that ST 16 is clonally distributed [25].

S. gallolyticus subsp. pasteurianus, formerly named Streptococcus bovis biovar II/2 [26,27] was the third most commonly isolated pathogen associated with four of the UTIs (Table  1). This species has previously been reported from cases of bacteraemia and endocarditis as well as urinary tract infections [26]. Murdoch et al.[28] reported S. bovis as an emerging pathogen associated with infective endocarditis and as the fourth most common cause of this disease in a multinational survey from 2000 to 2005. However, reports of UTI due to this organism are rare, and future investigations are needed to establish the role of S. gallolyticus subsp. pasteurianus in UTI.

Conclusions

The aetiology of the UTIs seen among patients in Hanoi, Vietnam differed from acute uncomplicated UTI seen elsewhere as they were often recurrent, chronic and self-medicated. E. faecalis was the main pathogen associated with UTI in Vietnamese women and a possible selection associated with indiscriminate use of antimicrobials warrants further investigation. ST 16 was the dominating E. faecalis MLST type (44.4%) and their high genetic similarity as shown by PFGE to ST 16 isolates recovered from Danish endocarditis patients indicates that E. faecalis ST 16 is clonally distributed. Further studies are needed to establish the source(s) and role of E. faecalis ST 16 in UTI. The study was limited by a relative low number of UTI cases (49). Also, the aetiology of the UTI could have been strengthen by bacterial culture of two consecutive collected urine samples and using a definition of ≥ 105 CFU per ml urine as a positive urine sample.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

LLP participated in the study design, carried out laboratory work, analyzed the data and drafted and edited the manuscript. MB participated in the study design, analyzed data and edited the manuscript. NTS, NVT and HMA conceive participated in the study design and coordination and collected the specimens. AD participated in the study design, analyzed data and edited the manuscript. All authors have read and approved the manuscript.

Acknowledgements

The study was supported by the University of Copenhagen through an ordinary PhD stipend to Louise L. Poulsen. The Danish International Development Assistance (Danida) provided financial support via the project “Chickens as a possible reservoir for urinary tract infections in humans”. Flemming Scheutz is greatly acknowledged for his engagement and advices during the development of the protocols and Jørgen Kurtzhals for critical review and comments on the manuscript. Staffs at the Army Hospital 103, Ha Dong, Hanoi as well as Nina Flint and Gitte Petersen are greatly acknowledged for their excellent technical and laboratory support. Office staff from the SANIVAT project “Water supply, sanitation, hygiene promotion and health in Vietnam” supported by the Danish International Development Assistance (Danida; 104.DAN.8.L.711) are thanked for their help to establish personal contacts and with logistic matters.

References

  1. Foxman B: Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs.

    Dis Mon 2003, 49:53-70. PubMed Abstract | Publisher Full Text OpenURL

  2. Lee JBL, Neild GH: Urinary tract infection.

    Medicine 2007, 35:423-428. Publisher Full Text OpenURL

  3. Kahlmeter G: An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project.

    J Antimicrob Chemother 2003, 51:69-76. PubMed Abstract | Publisher Full Text OpenURL

  4. Wilson ML, Gaido L: Laboratory diagnosis of urinary tract infections in adult patients.

    Clin Infect Dis 2004, 38:1150-1158. PubMed Abstract | Publisher Full Text OpenURL

  5. Nys S, Merode TV, Bartelds AIM, Stobberingh EE: Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture.

    J Antimicrob Chemother 2006, 57:955-958. PubMed Abstract | Publisher Full Text OpenURL

  6. Felmingham D, Wilson APR, Quintana AI, Gruneberg RN: Enterococcus species in urinary-tract infection.

    Clin Infect Dis 1992, 15:295-301. PubMed Abstract | Publisher Full Text OpenURL

  7. Bowler ICJV: Nosocomial infections. [http:/ / otm.oxfordmedicine.com/ cgi/ content/ essentials/ med-9780199204854-chapter-070203] webcite

    In Oxford Textbook of Medicine 5th edition. Edited by Warrel DA, Cox TM, Firth JD. Oxford University Press; 2010. OpenURL

  8. Murray BE: The life and times of the Enterococcus.

    Clin Microbiol Rev 1990, 3:46-65. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  9. Baddour LM, Wilson WR, Bayer AS, Fowler VG, Bolger AF, Levison ME, et al.: Infective endocarditis - Diagnosis, antimicrobial therapy, and management of complications - A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association.

    Circulation 2005, 111:394-434. PubMed Abstract | Publisher Full Text OpenURL

  10. Okumura J, Wakai S, Umenai T: Drug utilisation and self-medication in rural communities in Vietnam.

    Soc Sci Med 2002, 54:1875-1886. PubMed Abstract | Publisher Full Text OpenURL

  11. Huong NM, Gammeltoft T, Rasch V: Strategies for the prevention and treatment of reproductive tract infections among women in Vietnam.

    Cult Health Sex 2008, 10:111-122. Publisher Full Text OpenURL

  12. Blom M, Sorensen TL, Espersen F, Frimodt-Moller N: Validation of FLEXICULT (TM) SSI-urinary kit for use in the primary health care setting.

    Scand J Infect Dis 2002, 34:430-435. PubMed Abstract | Publisher Full Text OpenURL

  13. Dutka-malen S, Evers S, Courvalin P: Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.

    J Clin Microbiol 1995, 33:24-27. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  14. Angen O, Ahrens P, Tegtmeier C: Development of a PCR test for identification of Haemophilus somnus in pure and mixed cultures.

    Vet Microbiol 1998, 63:39-48. PubMed Abstract | Publisher Full Text OpenURL

  15. Dewhirst FE, Paster BJ, Olsen I, Fraser GJ: Phylogeny of 54 representative strains of species in the family Pasteurellaceae as determined by comparison of 16S rRNA sequences.

    J Bacteriol 1992, 174:2002-2013. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  16. Glazunova O, Raoult D, Roux V: Partial sequence comparison of the rpoB, sodA, groEL and gyrB genes within the genus Streptococcus.

    Int J Syst Evol Microbiol 2009, 59:2317-2322. PubMed Abstract | Publisher Full Text OpenURL

  17. Vakulenko SB, Donabedian SM, Voskresenskiy AM, Zervos MJ, Lerner SA, Chow JW: Multiplex PCR for detection of aminoglycoside resistance genes in enterococci.

    J Antimicrob Agents Chemother 2003, 47:1423-1426. Publisher Full Text OpenURL

  18. Hodel-christian SL, Murray BE: Characterization of the gentamicin resistance transposon Tn5281 from Enterococcus faecalis and comparison to staphylococcal transposons Tn4001 and Tn4031.

    J Antimicrob Agents Chemother 1991, 35:1147-1152. Publisher Full Text OpenURL

  19. Larsen J, Schonheyder HC, Lester CH, Olsen SS, Porsbo LJ, Garcia-Migura L, et al.: Porcine-origin gentamicin-resistant Enterococcus faecalis in humans, Denmark.

    Emerg Infect Dis 2010, 16:682-684. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  20. Murray BE, Singh KV, Heath JD, Sharma BR, Weinstock GM: Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites.

    J Clin Microbiol 1990, 28:2059-2063. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  21. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al.: Interpreting chromosomal DNA restriction patterns produced by Pulsed-Field Gel-Electrophoresis: Criteria for bacterial strain typing.

    J Clin Microbiol 1995, 33:2233-2239. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  22. Hart CA, Kariuki S: Antimicrobial resistance in developing countries.

    Br Med J 1998, 317:647-650. Publisher Full Text OpenURL

  23. Papaparaskevas J, Vatopoulos A, Tassios PT, Avlami A, Legakis NJ, Kalapothaki V: Diversity among high-level aminoglycoside-resistant enterococci.

    J Antimicrob Agents Chemother 2000, 45:277-283. Publisher Full Text OpenURL

  24. Hammerum AM, Olsen SS, Skjøt-Rasmussen L, DANMAP 2010: Use of antimicrobial agents and occurence of antimicrobial resistance in food animals, food and humans in Denmark. Copenhagen: DANMAP; 2010. OpenURL

  25. Ruiz-Garbajosa P, Bonten MJM, Robinson DA, Top J, Nallapareddy SR, Torres C, et al.: Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in a background of high rates of recombination.

    J Clin Microbiol 2006, 44:2220-2228. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  26. Schlegel L, Grimont F, Ageron E, Grimont PAD, Bouvet A: Reappraisal of the taxonomy of the Streptococcus bovis /Streptococcus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus subsp. nov and S. gallolyticus subsp pasteurianus subsp. nov.

    Int J Syst Evol Microbiol 2003, 53:631-645. PubMed Abstract | Publisher Full Text OpenURL

  27. Poyart C, Quesne G, Trieu-Cuot P: Taxonomic dissection of the Streptococcus bovis group by analysis of manganese-dependent superoxide dismutase gene (sodA) sequences: reclassification of ‘Streptococcus infantarius subsp coli’ as Streptococcus lutetiensis sp nov and of Streptococcus bovis biotype II.2 as Streptococcus pasteurianus sp nov.

    Int J Syst Evol Microbiol 2002, 52:1247-1255. PubMed Abstract | Publisher Full Text OpenURL

  28. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG, Bayer AS, et al.: Clinical presentation, etiology, and outcome of infective endocarditis in the 21st Century.

    Arch Intern Med 2009, 169:463-473. PubMed Abstract | Publisher Full Text OpenURL

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2334/12/320/prepub